Introduction
TNFot is a multi-functional cytokine which was originally identified as a serum factor that induced necrotic responses of solid tumours in vivo. Although TNFot exerts antitumour effects against various tumour cell lines, >3 it also has hypotensive 4, 5 or tumour metastasis-enhancing effects. Moreover, TNFot induces shock and injury including intestinal necrosis in rats or mice when it is administered with or without LPS. 4 At necropsy, several gross abnormalities of the caecum including marked thickening of the walls or focal haemorrhage were apparent in rats injected with TNF0t. Histopathological sections through the caecum 6 h after TNF0t injection (20 lag) revealed an inflammatory response with haemorrhage in the lamina propria mucosae or infiltration of leukocytes (Fig. 1A) . The venule of the tunica submucosa was dilated, and invasion of leukocytes was also observed. A detailed histopathological examination of the venule revealed the adhesion of neutrophils on the vessel wall or infiltration into the surrounding mucosal tissues (Fig. 1B) . In contrast, rats injected with F4168 had a reduced inflammatory response compared with the TNF0t administered group. Haemorrhage was rarely observed (Fig. 1D) , and the number of lymphocytes or neutrophils adhering or infiltrating in mucosa was relatively small in the F4168 administered group (Fig. 1E) . Table 1 was almost the same, the maximal expression (4 or 6 h after stimulation) by F4168 was significantly lower than that by TNF0t (Fig. 3) . Moreover, the ELAM-1 induction by TNF0t was dose dependent at concentrations of 0.01 to 10 ng/ml (Fig. 4) concentration tested except 10 ng/ml (Fig. 4) . Similar results were also obtained with respect to ICAM-1 (Fig. 5B) (Fig. 6) . Therefore, this mutein should be a useful antitumour drug without the side effects of wild-type TNF0t.
